Group One Trading
ENTX icon

Group One Trading’s Entera Bio ENTX Stock Holding History

Group One Trading’s Portfolio ENTX Stock Details ENTX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2022
Q1 		– Sell
-3,300
Closed -$9K – 8192
2021
Q4 		$9K Sell
3,300
-200
-6% -$749 ﹤0.01% 7391
2021
Q3 		$16K Sell
3,500
-600
-15% -$3.08K ﹤0.01% 7288
2021
Q2 		$25K Buy
+4,100
New +$15.2K ﹤0.01% 7050

Other funds holding ENTX

KCM
Knoll Capital Management Miami, Florida $214M AUM 62.74% 1-Year Est. Return
BI
BVF Inc San Francisco, California $3.91B AUM 304.52% 1-Year Est. Return
SL
Siren LLC Greenwich, Connecticut $4.94B AUM 244.43% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $72.6B AUM 54.88% 1-Year Est. Return
PHP
Parkman Healthcare Partners Stamford, Connecticut $977M AUM 110.37% 1-Year Est. Return
PNC Financial Services Group
PNC Financial Services Group Pittsburgh, Pennsylvania $202B AUM 37.79% 1-Year Est. Return
SFCM
Seven Fleet Capital Management Mountain View, California $606M AUM
HighTower Advisors
HighTower Advisors Chicago, Illinois $104B AUM 28.3% 1-Year Est. Return
HF
HRT Financial New York $54.8B AUM 81.03% 1-Year Est. Return
SSA
Schonfeld Strategic Advisors New York $27.9B AUM 51.18% 1-Year Est. Return

Group One Trading's ENTX Position: Q2 2026 in Review

Group One Trading held its Entera Bio (ENTX) position steady in Q2 2026 at 51 shares worth $90. The position accounts for ﹤0.01% of the portfolio, ranked #7413.

Group One Trading first reported a position in ENTX in Q3 2023 and has held it in 12 quarters since. The position peaked at $250 in Q3 2023. 27 funds tracked by Wall St. Rank hold ENTX as of Q2 2026.

  • Group One Trading held 51 shares of Entera Bio worth $90 as of Q2 2026.
  • Group One Trading left its Entera Bio share count unchanged in Q2 2026.
  • Entera Bio made up ﹤0.01% of Group One Trading's portfolio in Q2 2026, its #7413 holding.
  • Group One Trading first reported a position in Entera Bio in Q3 2023 and has held it in 12 quarters since.
  • Group One Trading's Entera Bio position peaked at $250 in Q3 2023.
  • 27 funds tracked by Wall St. Rank held Entera Bio as of Q2 2026.

Based on Group One Trading's 13F filing for Q2 2026, filed 14 Aug 2026.